重药控股：2025年半年度净利润约2.82亿元，同比增加18.56%

Core Insights - The company reported a revenue of approximately 41.188 billion yuan for the first half of 2025, representing a year-on-year increase of 3.54% [2] - The net profit attributable to shareholders was approximately 282 million yuan, showing a year-on-year increase of 18.56% [2] - The basic earnings per share were 0.16 yuan, reflecting a year-on-year increase of 14.29% [2]